Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.

The aim of this paper is to assess the usefulness of measuring serum levels of adalimumab (ADL) and anti-ADL antibodies in 57 patients with rheumatoid arthritis (RA) treated with ADL for at least 3 months in daily practice.

Detalles Bibliográficos
Autores: Rosas J, Llinares-Tello F, de la Torre I, Santos-Ramírez C, Senabre-Gallego JM, Valor L, Barber-Vallés X, Hernández-Flórez D, Santos-Soler G, Salas-Heredia E, Carreño L, AIRE-MB Group
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2014
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p7025
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/7025
Access Level:acceso abierto
id ES_b904e5dc17a243f8a4e73894f648f3cf
oai_identifier_str oai:fisabio.fundanetsuite.com:p7025
network_acronym_str ES
network_name_str España
repository_id_str
spelling Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.Rosas JLlinares-Tello Fde la Torre ISantos-Ramírez CSenabre-Gallego JMValor LBarber-Vallés XHernández-Flórez DSantos-Soler GSalas-Heredia ECarreño LAIRE-MB GroupThe aim of this paper is to assess the usefulness of measuring serum levels of adalimumab (ADL) and anti-ADL antibodies in 57 patients with rheumatoid arthritis (RA) treated with ADL for at least 3 months in daily practice.CLINICAL & EXPER RHEUMATOLOGY2014info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/7025CLINICAL AND EXPERIMENTAL RHEUMATOLOGYISSN: 0392856XISSNe: 1593098Xreponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p70252026-06-11T12:45:17Z
dc.title.none.fl_str_mv Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
spellingShingle Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
Rosas J
title_short Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title_full Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title_fullStr Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title_full_unstemmed Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
title_sort Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
dc.creator.none.fl_str_mv Rosas J
Llinares-Tello F
de la Torre I
Santos-Ramírez C
Senabre-Gallego JM
Valor L
Barber-Vallés X
Hernández-Flórez D
Santos-Soler G
Salas-Heredia E
Carreño L
AIRE-MB Group
author Rosas J
author_facet Rosas J
Llinares-Tello F
de la Torre I
Santos-Ramírez C
Senabre-Gallego JM
Valor L
Barber-Vallés X
Hernández-Flórez D
Santos-Soler G
Salas-Heredia E
Carreño L
AIRE-MB Group
author_role author
author2 Llinares-Tello F
de la Torre I
Santos-Ramírez C
Senabre-Gallego JM
Valor L
Barber-Vallés X
Hernández-Flórez D
Santos-Soler G
Salas-Heredia E
Carreño L
AIRE-MB Group
author2_role author
author
author
author
author
author
author
author
author
author
author
description The aim of this paper is to assess the usefulness of measuring serum levels of adalimumab (ADL) and anti-ADL antibodies in 57 patients with rheumatoid arthritis (RA) treated with ADL for at least 3 months in daily practice.
publishDate 2014
dc.date.none.fl_str_mv 2014
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/7025
url https://fisabio.portalinvestigacion.com/publicaciones/7025
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv CLINICAL & EXPER RHEUMATOLOGY
publisher.none.fl_str_mv CLINICAL & EXPER RHEUMATOLOGY
dc.source.none.fl_str_mv CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
ISSN: 0392856X
ISSNe: 1593098X
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417698282176512
score 15,812429

Similares en LA Referencia